The nucleolus, a dense structure inside the cell’s nucleus, is the primary factory that makes ribosomes. It produces the RNA scaffolding, combines it with dozens of proteins, and assembles nearly complete ribosomal subunits before shipping them out to the rest of the cell. The process is one of the most energy-intensive jobs a cell performs, and it requires coordination between three different enzyme systems, multiple transport steps, and constant signaling based on whether the cell has enough nutrients to justify making more.
The Nucleolus: A Ribosome Factory
Every cell that needs to make proteins (which is essentially every cell) devotes a significant portion of its nuclear space to ribosome production. The nucleolus isn’t surrounded by its own membrane like the nucleus itself. Instead, it forms naturally around the clusters of genes that encode ribosomal RNA. Under a microscope, it has three visible zones: a fibrillar center where ribosomal genes sit, a dense fibrillar region where those genes are actively read and the initial RNA processing begins, and a granular region where the RNA gets assembled with proteins into nearly finished ribosomal subunits.
The production of ribosomal RNA accounts for a staggering share of nuclear activity. Transcription of ribosomal RNAs and transfer RNAs together makes up roughly 80% of all transcription happening in the nucleus. That gives you a sense of how central ribosome manufacturing is to cellular life.
How Ribosomal RNA Gets Made
Ribosomes are built from two raw materials: ribosomal RNA (rRNA) and ribosomal proteins. The RNA portion is the structural and functional backbone, and it gets made first. In human cells, a specialized enzyme called RNA Polymerase I reads a long stretch of DNA inside the nucleolus and produces a single massive RNA molecule known as the 47S precursor. This precursor is like a three-in-one package. It contains three of the four rRNA types the cell needs (called 18S, 5.8S, and 28S), separated by spacer sequences that will be trimmed away.
Processing begins while the precursor is still being made. Enzymes cut out the spacer regions to release the three individual rRNAs. The 18S rRNA will become part of the small ribosomal subunit, while the 5.8S and 28S rRNAs go into the large subunit.
There’s a fourth rRNA, called 5S, that the cell also needs for the large subunit. This one is made outside the nucleolus by a different enzyme, RNA Polymerase III. Once produced, the 5S rRNA travels into the nucleolus to join the assembly process. RNA Polymerase III also makes transfer RNAs, which ribosomes will eventually use when translating proteins, so it plays a supporting role in the broader protein-making system.
Where Ribosomal Proteins Come From
The 79 ribosomal proteins in a human ribosome are encoded by genes in the nucleus, but those genes are read by a third enzyme, RNA Polymerase II, the same one that makes messenger RNA for all other proteins. The resulting messenger RNAs travel out to existing ribosomes in the cytoplasm, which translate them into ribosomal proteins. Those freshly made proteins then need to travel back into the nucleus and specifically into the nucleolus, creating a loop: ribosomes help build the parts for new ribosomes.
Getting those proteins back into the nucleus requires dedicated transport carriers. At least four different import receptors grab ribosomal proteins and shuttle them through the nuclear pore complex, the gatekeeper channels in the nuclear membrane. Individual ribosomal proteins aren’t picky about which carrier they use. A single protein can be imported by any of the four receptors, which likely helps keep the supply chain moving even if one transport route gets congested.
Assembly and Export
Inside the nucleolus, ribosomal proteins begin binding to the precursor RNA before it’s even fully processed. More than half of the proteins latch on while the spacer regions are still being cut away. The remaining proteins and the 5S rRNA join as processing continues. This overlapping timeline, where assembly happens alongside RNA trimming, speeds up the whole operation considerably.
The result is two types of pre-ribosomal particles: a smaller one built around the 18S rRNA and a larger one containing the 28S, 5.8S, and 5S rRNAs. These particles aren’t quite finished yet. They’re exported through nuclear pores into the cytoplasm, where the final maturation steps occur. Only then do they become fully functional 40S (small) and 60S (large) ribosomal subunits. When a cell needs to make a protein, one small and one large subunit come together on a messenger RNA strand to form an active 80S ribosome.
How the Cell Controls Ribosome Production
Cells don’t make ribosomes at a constant rate. Production scales up or down depending on nutrient availability, growth signals, and energy supply. The central regulator is a signaling hub called mTORC1, which integrates information about amino acids, glucose, oxygen, and growth factors. When conditions are favorable, mTORC1 activates and drives ribosome production by boosting the activity of RNA Polymerase I and III, increasing rRNA output. It also ramps up transcription of the genes encoding ribosomal proteins.
When mTORC1 is suppressed, either by nutrient deprivation or specific inhibitors, the effect is broad and coordinated. Expression of genes for both large and small subunit proteins drops significantly, along with genes involved in protein synthesis and energy metabolism. This makes biological sense: if the cell doesn’t have enough raw materials to build new proteins, there’s no point manufacturing the machinery to do it.
The energy cost of ribosome production and use is substantial. In a rapidly growing bacterial cell, ribosome-driven protein synthesis consumes roughly 50% of the cell’s total energy. In mammalian cells that are actively growing or differentiating, the figure is around 30%. This is why the cell monitors its conditions so carefully before committing to making more ribosomes.
What Happens When Ribosome Production Goes Wrong
Because ribosome assembly involves so many genes and so many steps, mutations at various points can cause disease. A group of conditions called ribosomopathies result from inherited defects in ribosomal proteins or in the machinery that processes rRNA. The most well-known is Diamond-Blackfan anemia, caused by mutations in genes encoding ribosomal proteins. It leads to severe anemia because the bone marrow can’t produce enough red blood cells.
Other ribosomopathies include Shwachman-Diamond syndrome, dyskeratosis congenita, cartilage-hair hypoplasia, and Treacher Collins syndrome. Despite being caused by defects in a universal process (every cell needs ribosomes), these diseases tend to affect specific tissues, most commonly bone marrow and skeletal or craniofacial development. The reasons for this tissue selectivity are still not fully understood, but rapidly dividing cells that need large numbers of ribosomes appear to be most vulnerable when production falters.